Studying interactions involving the T-cell antigen receptor by surface plasmon resonance

Current Opinion in Immunology

Volumn 8, Issue 2, 1996, Pages 262-270

  Margulies, David H ^a   Plaksin, Daniel ^a   Khilko, S N ^a   Jelonek, Marie T ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; SUPERANTIGEN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; BINDING KINETICS; HALF LIFE TIME; LIGAND BINDING; MOLECULAR INTERACTION; RECEPTOR AFFINITY; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0030022868     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80066-5     Document Type: Article

References (56)

1. Germain RN, Margulies DH: The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993, 11:403-450.
2. Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994, 76:287-299.
3. Jönsson U, Fègerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K, Löfās S, Persson B, Roos H, Rünnberg I et al.: Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 1991, 11:620-627.
4. Hedrick SM, Eidelman FJ: T-Lymphocyte antigen receptors. In Fundamental Immunology, 3rd edn. Edited by Paul WE. New York: Raven Press; 1993:383-420.
5. Samelson LE, Donovan JA, Isakov N, Ota Y, Wange RL: Signal transduction mediated by the T-cell antigen receptor. Ann N Y Acad Sci 1995, 766:157-172.
6. Yewdell JW, Bennink JR: The binary logic of antigen processing and presentation to T cells. Cell 1990, 62:203-206.
7. Kotzin BL, Leung DY, Kappler J, Marrack P: Superantigens and their potential role in human disease. Adv Immunol 1993, 54:99-166.
8. Raether H: Surface Plasmons on Smooth and Rough Surfaces and on Gratings. Berlin: Springer-Verlag: 1988.
9. Johnsson B, Löfās S, Lindquist G: Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 1991, 198:268-277.
10. Liedberg B, Nylander C, Lundstrüm I: Biosensing with surface plasmon resonance - how it all started. Biosens Bioelectron 1995, 10:i-ix. A concise description of the conception and early application of SPR.
11. Cush R, Cronin JM, Stewart WJ, Maule CH, Molloy J, Goddard NJ: The resonant mirror - a novel optical biosensor for direct sensing of biomolecular interactions. 1. Priniciple of operation and associated instrumentation. Biosens Bioelectron 1993, 8:347-353.
12. Tiefenthaler K: Grating couplers as label-free biochemical waveguide sensors. Biosens Bioelectron 1993, 8:xxv-xxxvii.
13. Babbitt B, Allen P, Matsueda G, Haber E, Unanue E: Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 1985, 317:359-361.
14. Buus S, Sette A, Colon S, Jenis D, Grey H: Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 1986, 47:1071-1077.
15. Townsend A, Elliott T, Cerundolo V, Foster L, Barber B, Tse A: Assembly of MHC class I molecules analyzed in vitro. Cell 1990, 62:285-295.
16. Boyd LF, Kozlowski S, Margulies DH: Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of β2-microglobulin. Proc Natl Acad Sci USA 1992, 89:2242-2246.
17. Chen B, Parham P: Direct binding of influenza peptides to class I HLA molecules. Nature 1989, 337:743-745.
18. b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supernatants. Proc Natl Acad Sci USA 1986, 83:5252-5256.
19. ds: sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med 1992, 176:1681-1692.
20. d exploits, a four residue peptide binding motif. J Exp Med 1993, 178:1877-1892.
21. Catipovic B, Dal Porto J, Mage M, Johansen TE, Schneck JP: Major histocompatibility complex conformational epitopes are peptide specific. J Exp Med 1992, 176:1611-1618.
22. Sherman LA, Chattopadhyay S, Biggs JA, Dick RF, Bluestone JA: Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Acad Sci USA 1993, 90:6949-6951.
23. Fahnestock ML, Johnson JL, Feldman RM, Tsomides TJ, Mayer J, Narhi LO, Bjorkman PJ: Effects of peptide length and composition on binding to an empty class I MHC heterodimer. Biochemistry 1994, 33:8149-8158.
24. Fahnestock ML, Dadgari JM, McMillan M, Bjorkman PJ: Phosphatidyl inositol-linked forms of a murine class I MHC molecule expressed on Chinese hamster ovary cells retain peptide binding capability and alloreactivity. Int Immunol 1994, 6:307-314.
25. Fahnestock ML, Tamir I, Narhi L, Bjorkman PJ: Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science 1992, 258:1658-1662.
26. Jackson MR, Cohendoyle MF, Peterson PA, Williams DB: Regulation of MHC class-I transport by the molecular chaperone, calnexin (P88, IP90). Science 1994, 263:384-387.
27. Khilko SN, Corr M, Boyd LF, Lees A, Inman JK, Margulies DH: Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J Biol Chem 1993, 268:15425-15434.
28. Margulies DH, Cor M, Boyd LF, Khilko SN: MHC class I/peptide interactions: binding specificity and kinetics. J Mol Recog 1993, 6:59-69.
29. Khilko SN, Jelonek MT, Corr M, Boyd LF, Bothwell ALM, Margulies DH: Measuring interactions of MHC class I molecules using surface plasmon resonance. J Immunol Methods 1995, 183:77-94. This review presents primary kinetic data on MHC-peptide interactions gathered using SPR.
30. Silver ML, Guo HC, Strominger JL, Wiley DC: Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992, 360:367-369.
31. b binding to immobilized analogs of the two peptides by SPR suggest that immunogenicity is related to the kinetics of MHC-I binding.
32. Northrup SH, Erickson HP: Kinetics of protein-protein association explained by Brownian dynamics computer simulation. Proc Natl Acad Sci USA 1992, 89:3338-3342.
33. Schneck J, Maloy WL, Coligan JE, Margulies DH: Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 1989, 56:47-55.
34. Weber S, Traunecker A, Oliveri F, Gerhard W, Karjalainen K: Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 1992, 356:793-796.
35. Matsui K, Boniface JJ, Reay PA, Schild H, Fazekas de St Groth B, Davis MM: Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 1991, 254:1788-1791.
36. Corr M, Slanetz AE, Boyd LF, Jelonek MT, Khilko S, Al-Ramadi BK, Kim YS, Maher SE, Bothwell AL, Margulies DH: T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 1994, 265:946-949. A demonstration of the direct binding of TCR to MHC-peptide complexes using SPR. Both kinetic and equilibrium determinations indicate moderate affinity and rapid dissociation rate. The implications for the mechanism of binding are discussed.
37. Slanetz AE, Bothwell AL: Heterodimeric, disulfide-linked alpha/beta T cell receptors in solution. Eur J Immunol 1991, 21:179-183.
38. Kranz DM, Sherman DH, Sitkovsky MV, Pasternack MS, Eisen HN: Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc Natl Acad Sci USA 1984, 81:573-577.
39. Udaka K, Tsomides T, Eisen H: A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 1992, 69:989-998.
40. Udaka K, Tsomides TJ, Walden P, Fukusen N, Eisen HN: A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc Natl Acad Sci USA 1993, 90:11272-11276.
41. Metzger H: Transmembrane signaling: the joy of aggregation. J Immunol 1992, 149:1477-1487.
42. Karjalainen K: High sensitivity, low affinity-paradox of T-cell receptor recognition. Curr Opin Immunol 1994, 6:9-12.
43. McKeithan TW: Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci USA 1995, 92:5042-5046.
44. Sykulev Y, Brunmark A, Tsomides TJ, Kageyama S, Jackson M, Peterson PA, Eisen HN: High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci USA 1994, 91:11487-11491.
45. Boniface JJ, Davis MM: The kinetics of binding of peptide/MHC complexes to T-cell receptors: application of surface plasmon resonance to a low-affinity measurement. Methods Compan Methods Enzymol 1994, 6:168-175. Presents SPR measurements of direct binding of MHC-II-peptide complexes to clone-specific TCRs. This paper emphasizes the value of SPR for detecting low-affinity interactions.
46. k complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994, 91:12862-12866. SPR measurements of several different MHC-II-peptide complexes to TCR are reported. This study provides data to support the notion that functional outcome in T cell activation is directly related to stability of TCR-MHC-peptide complex.
47. Al-Ramadi BK, Jelonek MT, Boyd LF, Margulies DM, Bothwell ALM: Lack of strict correlation of functional sensitization with the apparent affinity of MHC-peptide complexes for the T cell receptor. J Immunol 1995, 155:662-673. Comprehensive analysis by SPR of the functional and binding properties of single-site substitutions of the p2Ca peptide. Although most of the functional results correlate with the strength of formation of the TCR-MHC/peptide complex, one clear example indicates that measured binding is not directly related to T-cell recognition.
48. Hilyard KL, Reyburn H, Chung S, Bell JI, Strominger JL: Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli. Proc Natl Acad Sci USA 1994, 91:9057-9061.
49. Malchiodi EL, Eisenstein E, Fields BA, Ohlendorf DH, Schlievert PM, Karjalainen K, Mariuzza RA: Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med 1995, 182:1833-1845. A comprehensive evaluation, using SPR, of binding of superantigens to purified TCR, TCR β chain, and TCR V α domain. SPR values are also compared with those obtained by equilibrium sedimentation.
50. Seth A, Stern LJ, Ottenhoff TH, Engel I, Owen MJ, Lamb JR, Klausner RD, Wiley DC: Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 1994, 369:324-327. A demonstration, using SPR, of the binding interactions of TCR with SEB, and of SEB-MHC-II with TCR.
51. Korono H, Parker D, White J, Marrack P, Kappler J: Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity 1995, 3:187-196. A careful SPR analysis of the interactions of SEA and SEB with various MHC-II-peptide complexes.
52. Demotz S, Grey H, Sette A: The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 1990, 249:1028-1030.
53. Christinck E, Luscher M, Barber B, Williams D: Peptide binding to class I MHC on living cells and quantitation of compolexes required for CTL lysis. Nature 1991, 352:62-70.
54. Brower RC, England R, Takeshita T, Kozlowski S, Margulies DH, Berzofsky JA, Delisi C: Minimal requirements for peptide mediated activation of CD8(+) CTL. Mol Immunol 1994, 31:1285-1293.
55. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995, 375:148-151.
56. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM: Kinetic discrimination in T cell activation. Proc Natl Acad Sci USA 1996, 93:in press. A kinetic model for the mechanism of peptide antagonism, based on the kinetic data derived from of TCR-MHC/peptide binding studies.